About Drupal 8
Have you ever felt that your website needs to be more personalized, integrated with cutting-edge technology to offer enhanced user experience?
Valuebound is one of those companies, which specifically help organizations in their path to digital transformation. We enhance digital experience for end users with tailored web applications.
Recent releases
|
Optimizing Navigation for a Seamless Educational Platforms
Navigating the Educational Landscape: Enhancing User Experience on Educational Platforms
In today's knowledge-driven world, educational platforms have become indispensable tools for learning,…
|
How to Enhance Navigation on Your Streaming Platform
Introduction
In the era of digital entertainment, streaming platforms have emerged as the go-to destination for an unprecedented expanse of TV shows, movies, documentaries, and other…
|
Top Benefits of AWS for Educational Institutions
Introduction
A. Overview of AWS in the education sector
In an era where education and technology intersect, Amazon Web Services (AWS) stands as a cornerstone for educational institutions…
|
Top Benefits of AWS for Financial Institutions
Introduction
A. Overview of AWS in the financial sector
In the rapidly evolving landscape of finance, Amazon Web Services (AWS) emerges as a key player, revolutionizing how…
CASE STUDY
See all our work
How a Top Indian Pharma Brand Boosted HCP Engagement Using Tech-Led Omnichannel Marketing
India’s renowned pharmaceutical company, known for its strong presence in chronic therapy areas, was facing a growing disconnect with its most important audience: healthcare professionals.
How a Leading Indian Pharma Brand Expanded Reach Across Semi-Urban & Rural Regions
A leading pharmaceutical company in India, well known for its OTC presence and deep connection with mass-market audiences, was preparing to launch a public awareness campaign focused on maternal he
Driving Digital Engagement for a Chronic Care Program with Tech-Led Pharma Marketing
A leading pharmaceutical company in India, known for its chronic care drug portfolio, was preparing to launch a support program aimed at patients diagnosed with congestive heart failure (CHF).
